Six Hot Post Inauguration Trades: HSDT, INM, RGTI, EONR, QBTS, QUBT

DENVER, Colo., Jan 21, 2025 (247marketnews.com)- These are some of the hottest trades following yesterday’s inauguration.

Helius Medical (NASDAQ: HSDT), a neurotechnology company focused on innovative neuromodulation therapies for balance and gait deficits, has announced it has exceeded its enrollment target for its stroke registrational program. With 128 participants randomized as of December 31, 2024, the program is on track to reach the target of 150 participants by the end of January 2025.

InMed Pharmaceuticals (NASDAQ: INM) reported promising results from a long-term preclinical Alzheimer’s Disease (AD) study. INM-901 demonstrated a reduction in several markers of neuroinflammation, a known factor in Alzheimer’s development and progression.

Rigetti Computing (NASDAQ: RGTI), D-Wave Quantum (NYSE: QBTS), and Quantum Computing (NASDAQ: QUBT) seem to be rebounding from what appears to be an oversold reaction to NVIDIA CEO’s recent comments about quantum technology.

EON Resources (NYSE: EONR) is an independent upstream drill-baby-drill energy company with oil and gas properties in the Permian Basin.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (HSDT, INM, RGTI, QBTS, QUBT, EONR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.